ADJUVANT OF NOVEL CORONAVIRUS VACCINE AND USE THEREOF, AND BIVALENT RECOMBINANT VACCINE OF NOVEL CORONAVIRUS

• Main Authors: YUN, Bingling, YIN, Fei, JIANG, Xulin, GAO, Wenshuang, ZHANG, Haijiang, YANG, Xiufen, LIU, Yongjiang, WU, Shuming
• Format: Patent
• Language: Chinese; English; French
• Published: 28.03.2024
• Subjects: CHEMISTRY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PEPTIDES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

Disclosed in the present invention are an adjuvant for a novel coronavirus COVID-19 vaccine, and a developed bivalent vaccine thereof which contains antigens of a novel coronavirus epidemic HuB strain and a South African mutant strain B.1.351. La présente invention concerne un adjuvant pour un vaccin contre le coronavirus de la COVID-19, et un vaccin bivalent associé qui contient des antigènes d'une souche HuB de coronavirus et d'une souche mutante B.1.351 d'Afrique du sud. 本发明公开一种用于新型冠状病毒COVID-19疫苗的佐剂，及其含有新型冠状病毒流行HuB毒株和南非突变毒株B.1.351抗原研制的二价疫苗。